[ad_1] There is really no excuse not to have a mammogram. That's what Chris Roberts, a navigator at Sparks Women's Center in Fort Smith, said, who has heard all the excuses in …
Read More »
[ad_1] This is good news for women with triple-negative breast cancer, a form of aggressive, hard-to-treat breast cancer that targets women under 50 years of age. A new study published Saturday in …
Read More »
[ad_1] Three-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell membrane colored green. Image created in 2014 by Tom Misteli, Ph.D., and Karen Meaburn, …
Read More »
[ad_1] MUNICH (Reuters) – Roche's entrectinib-based cancer pill has been shown to reduce tumors in 57% of patients in a group that can only be identified by genetic profile, with the Swiss …
Read More »
[ad_1] The association of the drug Palbociclib, a recently developed drug, with hormone treatment dramatically extends the lives of women with advanced breast cancer, scientists said yesterday. Women with metastatic cancer and …
Read More »
[ad_1] BOZEMAN, Mount. – The Cancer Support Community hosted the second annual Warriors & Wine event Saturday at the Gallatin Valley Mall. The event was open to the public for a $ …
Read More »
[ad_1] 0 Survivors and Breast Cancer Awareness Supporters Walk to Take Action to Fight Breast Cancer CONCORD, N.C. – The zMAX Dragway in Concord was filled with pink as hundreds of walkers …
Read More »
[ad_1] Please activate Javascript to watch this video HARRISBURG, Dauphin County, PA – Thousands of people marched Saturday to raise awareness of breast cancer in Dauphin County. The American Cancer Society has …
Read More »
[ad_1] INVOICING – The scene was moving Friday night at the Billings MetraPark before the start of the NILE Rodeo. More than a dozen breast cancer survivors have been honored by entering …
Read More »
[ad_1] Massimo Cristofanilli, MD The association palbociclib (Ibrance) and fulvestrant (Faslodex) resulted in a clinically significant benefit in terms of overall survival (OS) in patients with advanced HER2-negative breast cancer presenting with …
Read More »